MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    A Phase 2 Randomized, Double-blind, Placebo-controlled Trial of PRAX-944 for the Treatment of Essential Tremor

    O. Olhaye, G. Belfort, S. Raines, T. Snyder, B. Ravina (Boston, USA)

    Objective: Evaluate the tolerability, safety and efficacy of PRAX-944, a selective small molecule T-type calcium channel blocker, for treatment of essential tremor (ET). Background: Essential…
  • 2022 International Congress

    The profile of dysautonomia in the early stages of Parkinson’s disease and multiple system atrophy: the importance of using the SCOPA-AUT scale

    M. Jecmenica-Lukic, I. Stankovic, A. Tomic, N. Kresojevic, V. Markovic, I. Petrovic, N. Dragasevic, M. Svetel, V. Kostic (Belgrade, Serbia)

    Objective: To examine the profile of autonomic dysfunction and the utility of the SCOPA-AUT scale in distinguishing patients with early Parkinson's disease (PD) and MSA-parkinsonism (MSA-P)…
  • 2022 International Congress

    Acute Stimulation-Induced Ataxia From Thalamic Deep Brain Stimulation

    V. Chandra, Y. Mehkri, A. Desai, C. Hanna, J. Hernandez, J. Yu, J. Frey, J. Wong, J. Hilliard, K. Foote (Gainesville, USA)

    Objective: To characterize stimulation-induced ataxia in Essential Tremor patients treated with VIM DBS. Background: In Essential tremor (ET) patients with medically refractory tremor, deep brain…
  • 2022 International Congress

    Automatic Speech Recognition for speech therapy in a Parkinson’s disease patient

    A. Nuzzi (Bari, Italy)

    Objective: The aim of the present study was to examine the Automatic Speech Recognition (ASR) technology as a useful approach to enhance the speech intelligibility…
  • 2022 International Congress

    Feasibility Of An Intensive Inpatient Parkinson’s Rehabilitation Program For Moderately Advanced Parkinson’s Disease

    L. Rubin, M. Mccrossin, C. Claro, A. Persaud, A. Hernandez, D. Barreto, K. Schlosser, E. Stack, P. Fischetti, J. Yu, D. Green, L. Ptarcinski, K. Greco, G. Fequiere, C. Francavilla, P. Moondra, A. Di Rocco (Glen Cove, USA)

    Objective: To determine the feasibility in the US of a multimodal intensive inpatient Parkinson’s Rehabilitation program for patients with moderately advanced Parkinson’s disease (PD) Background:…
  • 2022 International Congress

    A Mixed Methods Study on the Impact of Reading the Graphic Memoir My Degeneration: A Journey Through Parkinson’s on Patients with Parkinson’s Disease

    M. Green, S. de Jesus, D. George, L. van Scoy, K. Myers (Hershey, USA)

    Objective: To explore the impact of reading a graphic memoir on patients’ knowledge, mental health, and attitudes about living with Parkinson Disease (PD). Background: In…
  • 2022 International Congress

    Verifying imaging accuracy for targeting and lead positioning in DBS: a phantom study.

    A. Rohaan, Y. Willems, N. Vander Gaag (Leiden, Netherlands)

    Objective: In this phantom study we created an overview of the accuracy of four different modalities frequently used in DBS surgery and investigated the influence…
  • 2022 International Congress

    Oro-bucco-lingual dyskinesia as a side effect of methotrexate therapy

    H. Sarac, F. Borovecki, I. Sarac, N. Henigsberg (Zagreb, Croatia)

    Objective: to demonstrate association between the tardive dyskinesia and methotrexate therapy. Background: Dystonia is found among patients taking methotrexate. However, methotrexate and tardive oro-bucco-lingual dyskinesia…
  • 2022 International Congress

    Cognition in Huntington’s Disease

    A. Sethi, O. Kaczmarek, S. Baek, B. Bumstead, M. Buhse, M. Zarif, M. Gudesblatt (Patchogue, USA)

    Objective: Explore the cognitive profile of patients with Huntington’s Disease (HD) using a digital cognitive battery Background: Huntington’s Disease (HD) is a relentlessly progressive neurodegenerative…
  • 2022 International Congress

    Early intervention with deep brain stimulation for children with ε-sarcoglycan myoclonus dystonia

    A. Salazar, M. Correa-Vela, M. González, L. Ispierto, J. Ferrero-Turrion, G. Español, A. Bescós, M. Tardáguila, B. Pérez-Dueñas (Barcelona, Spain)

    Objective: To evaluate the efficacy and safety of Globus Pallidus Internus DBS (GPi-DBS) in early stages of disease course. Background: SGCE-related myoclonus-dystonia (SGCE-MD) is considered…
  • « Previous Page
  • 1
  • …
  • 683
  • 684
  • 685
  • 686
  • 687
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley